Home/Pipeline/Research Biosimilars

Research Biosimilars

Research-Grade Therapeutic Antibodies

CommercialActive

Key Facts

Indication
Research-Grade Therapeutic Antibodies
Phase
Commercial
Status
Active
Company

About ichorbio

IchorBio operates as a specialized reagent manufacturer in the life sciences tools sector, carving out a niche by supplying high-quality, in vivo-grade monoclonal antibodies. The company addresses a critical need in biomedical research for consistent and validated antibodies used in animal studies, which are foundational for therapeutic development. While currently positioned as a service and product provider, its expertise in antibody production and biosimilar development could provide a platform for future expansion into therapeutic antibody discovery or CMO services. Its private status and early commercial stage suggest a focus on establishing market presence and scaling operations within a competitive but essential segment of the biotech ecosystem.

View full company profile